Searched for
INHALATION INSULIN
Cipla appoints health chief Shivam Puri to lead One India businessCipla has appointed Shivam Puri as the new Chief Executive Officer for its One India Business. This significant leadership change will take...- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Cipla launches inhalable insulin for diabetes careCipla has launched a new orally inhaled insulin powder for diabetes patients in India. This needle-free alternative to injections offers a ...
- Cipla shares in focus after receiving CDSCO nod to launch inhalation insulinCipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers ...
- Cipla gets CDSCO nod to launch inhalation insulinCipla received approval from CDSCO to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers ...
- Cipla scales up offerings, investments as it eyes global lung specialty leadershipDrugmaker Cipla said it is scaling up offerings and expanding access to medicines, inhaler devices, diagnostics, as it aspires to become th...
- Amazon opens online pharmacy, shaking up another industryThe company opened an online pharmacy Tuesday, giving Amazon shoppers the chance to buy their medication and order refills on their phones ...
- Suffering from type 2 diabetes? New treatments can help control blood glucose levelOn World Diabetes Day, here's a list of new medications that will make life simpler for diabetics.
- Cipla’s inhalable insulin fails to get approval for trials on Indian patientsCipla had based its application to the panel on the bioequivalence studies with Exubra, an inhalation drug and device combination that was ...
- Novo Nordisk searches for tablet to replace insulin shotsThe company that reaped nearly 80% of its $16 billion sales from insulin products last year is hopeful for a regulatory approval for its fi...
- The Holy Grail: How Rani Therapeutics Is packing the insulin punch in pillsScientists couldn’t crack the science because enzymes in the stomach break down and digest the proteins, which are therefore not absorbed i...
- Arvind Kejriwal has high blood sugar level, to start insulin course: Family doctorArvind Kejriwal, who has been dogged of late by health problems, was today examined by his family doctor at the Secretariat here.
- Pfizer in $200 million insulin deal with BioconBiocon received $200 million upfront from New York-based Pfizerwhich is re-entering the $14-billion global insulin market almost four years...
- Very bullish on Glenmark: Aunali Rupani, ARM ResearchNext 5 years will see a big run up in all the pharma stocks in India especially R&D.
- Pfizer’s Q3 profit up on downsizing, higher salesPfizer, the world’s biggest drugmaker, said profit tripled because of higher sales of the pain pill Lyrica and lower costs from the 11,000 ...
- Pfizer warns of lung cancer link with inhaled insulinUS drugmakers Pfizer Inc and Nektar Therapeutics warned of cases of lung cancer in clinical trials of their inhaled insulin Exubera.
- First needle-free insulin soonBiotechnology company Shreya Lifesciences has entered into an in-licensing agreement with US-based Generex Biotechnology Corp to market Ora...
- Pfizer's profit falls on costs to end diabetic treatment salesPfizer, the world’s largest drugmaker, said third-quarter profit fell 77% on costs for ending sales of the diabetes treatment Exubera and c...
- Pfizer unveils first insulin inhaler in USAfter more than two decades of daily needle injections to treat his diabetes, Ken Wagner says he is eager to try Exubera, the first inhaled...
Load More
